GMP-TL778 Anti-Human CD137 mAb from China Suppliers - T Cell Proliferation & Cytokine Secretion Factory
Introduction to 4-1BB (CD137)
4-1BB, also known as CD137, is an inducible cell surface receptor and one member of the tumor necrosis factor receptor (TNFR) superfamily. CD137 is encoded by the tumor necrosis factor receptor superfamily member 9 (TNFRSF9) gene and is widely expressed on the surface of activated T cells and NK cells.
Key Immune Pathway Mediator
CD137 / CD137L mediate immune responses by transmitting activation, proliferation, or apoptotic signals between immune cells.
The Role of CD137L (Ligand)
Its ligand, CD137L, is also a TNFSF member and functions as an inducible costimulatory receptor. It is expressed by a wide range of immune cells, including:
- Activated CD4+ and CD8+ T cells (especially on CD8+ T cells)
- NKT and NK cells
- Dendritic Cells (DC) and macrophages
- Eosinophils, neutrophils, and mast cells
Immune Activation
The activation of CD137 can stimulate NK cell and T cell proliferation and generate anti-tumor activity, which induces durable memory responses.
Intracellular Signaling
4-1BB mAb can activate 4-1BB to recruit TNFR-related factors TRAF1 and TRAF2. These factors form a heterotrimer, strengthening signal transduction through c-Jun N-terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) pathways.
This resulting heterotrimer can stimulate the proliferation of T cells and antigen-presenting cells, improve the anti-tumor immune response of the body, and secrete cytokines through the transcription of NF-κB.

